Fortress Biotech
FBIO
#10163
Rank
ยฃ47.74 M
Marketcap
ยฃ1.43
Share price
-4.02%
Change (1 day)
-27.36%
Change (1 year)

Operating Margin for Fortress Biotech (FBIO)

Operating Margin as of November 2026 (TTM): 0.00%

According to Fortress Biotech 's latest financial reports and stock price the company's current Operating Margin is 0.00%. At the end of 2021 the company had an Operating Margin of -238.92%.

Operating Margin history for Fortress Biotech from 2016 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2021-238.92%5.93%
2020-225.55%-18.73%
2019-277.54%-42.96%
2018-486.57%828.3%
2017-52.42%-87.88%
2016-432.58%-93.07%
2015-6,243.68%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Veracyte
VCYT
20.64%N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-61.01%N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-399,877.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
11.12%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.